CHAPEL HILL, N.C., March 12 /PRNewswire/ -- R&D structure that promotes creativity, encourages innovation, and creates staffing efficiency is essential to pharmaceutical companies. In a competitive market space -- as the search for new products and process increases -- the need to have an optimized quality organization that supports R&D takes priority.
Discover the best-suited organizational structure that promotes rapid
growth, competitive edge, and reduced risks in the report, Optimizing the
R&D Quality Organization, from Best Practices LLC., a leading
pharmaceutical research company. This groundbreaking report analyzes how
-- Structure successful R&D Quality organizations
-- Maintain staffing levels for successful research quality
-- Outsource and oversee third-party activities
In addition, Optimizing the R&D Quality Organization is a tool for R&D Quality executives to successfully increase their efficiency, maintain superior product quality, and align their R&D Quality organization to effectively meet FDA regulations.
This Best Practices, LLC report contains best practices, in-depth company profiles and analysis that take a data-driven look on R&D Quality staffing, outsourcing and span of control. The report highlights industry leaders such as: Bristol-Myers Squibb, Medarex, Aventis, Amgen, Cardinal Health, GlaxoSmithKline, Abbott Laboratories, Eli Lilly, Johnson & Johnson.
To download a free report summary of Optimizing the R&D Quality Organization, visit http://www3.best-in-class.com/rr916.htm .
For more information, contact Cameron Tew (919) 767-9246 or at email@example.com
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a research and consulting firm that conducts
work based on the simple yet profound principle that organizations can
chart a course to superior economic performance by st
|SOURCE Best Practices, LLC|
Copyright©2008 PR Newswire.
All rights reserved